Obesity Clinical Trials in Chicago

Showing 61-80 of 242 trials

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

NCT06239116

The purpose of this study is to evaluate the safety, tolerability, and PK of RM-718 in healthy subjects with obesity and in patients with MC4R Pathway Impairment

Hypothalamic ObesityPrader-Willi SyndromePWS

Rhythm Pharmaceuticals, Inc.150 participantsStarted Mar 2024

Birmingham, Alabama, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +4 more locations

Active Not RecruitingPhase 42.2 miles

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

NCT06571383

The study is testing how well semaglutide can help adolescents with excess body weight to lose weight and to maintain weight loss. All participants in the study will receive semaglutide as a weekly injection. The study medicine is injected with a thin needle in the stomach, thighs or upper arms. All participants will get semaglutide treatment for a minimum of 3 years.

Obesity

Novo Nordisk A/S500 participantsStarted Sep 2024

Escondido, California, United States • Orlando, Florida, United States • Tallahassee, Florida, United States +90 more locations

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

Obesity Trials in Other Cities

Trial to Optimize Just-in-Time Adaptive Intervention for Binge Eating & Weight-related Behaviors

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients

DNA Methylation and Vascular Function

A Trial to Assess the Effects of Diets With and Without Inulin on Energy Expenditure in Adults.

A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity

A Study of LY3841136 in Overweight and Obese Participants

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities

Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy

A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight

A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

Lifestyle Intervention in Preparation for Pregnancy (LIPP)

Evaluation of Cognitive Improvement After Bariatric Surgery Using a Virtual Reality Program and the Neuropsi Neuropsychological Battery

Other Conditions in Chicago